|
Market Cap (4-Jul) $407,041,472 (439th) |
Close (30-Jun) $4.40 |
Volume (30-Jun) 565,229 |
Shortsold (19-Jun) 1,217,772 (1.50%) (163rd) |
|
52w High $7.31 |
52w Low $3.74 |
P/E 285.71 |
EPS -1.56 |
MYX released this announcement to the ASX on 13 October 2022, 14:24. The announcement is not marked as price sensitive, and is 27 page(s) in length and 802.71kb in size.
You can view all announcements from MYX and see how they appear on a price chart on the announcements page.
At the date of this announcement, MYX was 2.795% short sold according to ASIC data. It was ranked the 106th most shorted stock on the ASX. It remains ranked 163rd as of the latest reported data (19 June 2025).
| Other Recent Announcements from MYX | |
|---|---|
| Notification of cessation of securities - MYX | 30 June 2023, 16:11 |
| Update - Notification of buy-back - MYX | 30 June 2023, 8:19 |
| Update - Notification of buy-back - MYX | 29 June 2023, 8:20 |
| 2022 Corporate Governance Statement and Appendix 4G | 13 October 2022, 14:24 |
| Mayne Pharma completes sale of Metrics Contract Services | 4 October 2022, 13:14 |
| Initial Director's Interest Notice | 4 October 2022, 11:30 |
| Final Director's Interest Notice x2 | 4 October 2022, 11:29 |
You must be logged in to post a reply.
Mayne Pharma Group 